San Diego’s Small Cap Stocks Arrive in Force at Roth Capital’s Largest Investor Conference

biotechnology sector; the other addresses leading companies and pioneering treatments in the race to develop new anti-viral drug therapies.

—A track nearly as large features 90 companies based in China (but with stock that trades on U.S. markets). This morning’s China panel includes a discussion of case studies and lessons learned, conducting effective due diligence, assessment of company accounting capabilities, legal considerations, and other topics.

—Roth also has organized a cleantech investing panel on the changing landscape in power production and distribution that includes a discussion of electric grid modernization and the influence of federal stimulus funds, demand-side management, and the role natural gas is expected to play in future power generation.

All told, 21 San Diego companies also are scheduled to make presentations:

Alphatec Holdings     (NASDAQ: [[ticker:ATEC]])

Genoptix                     (NASDAQ: [[ticker:GXDX]])

Overland Storage       (NASDAQ: [[ticker:OVRL]])

Qualcomm                   (NASDAQ: [[ticker:QCOM]])

Cytori Therapeutics     (NASDAQ: [[ticker:CYTX]])

DexCom                        (NASDAQ: [[ticker:DXCM]])

NuVasive                       (NASDAQ: [[ticker:NUVA]])

Volcano                           (NASDAQ: [[ticker:VOLC]])

Cypress Bioscience       (NASDAQ: [[ticker:CYPB]])

NexMed                          (NASDAQ: [[ticker:NEXM]])

Santarus                          (NASDAQ: [[ticker:SNTS]])

DivX                                 (NASDAQ: [[ticker:DIVX]])

Maxwell Technologies   (NASDAQ: [[ticker:MXWL]])

Anadys Pharmaceutical  (NASDAQ: [[ticker:ANDS]])

Ardea Biosciences           (NASDAQ: [[ticker:RDEA]])

Inovio Biomedical               (NASDAQ: [[ticker:INO]])

Neurocrine Biosciences    (NASDAQ: [[ticker:NBIX]])

Vical Inc.                              (NASDAQ: [[ticker:VICL]])

Sequenom                           (NASDAQ: [[ticker:SQNM]])

Halozyme Therapeutics    (NASDAQ: [[ticker:HALO]])

Lifevantage                          (NASDAQ: [[ticker:LFVN]])

Senomyx                             (NASDAQ: [[ticker:SNMX]])


Author: Bruce V. Bigelow

In Memoriam: Our dear friend Bruce V. Bigelow passed away on June 29, 2018. He was the editor of Xconomy San Diego from 2008 to 2018. Read more about his life and work here. Bruce Bigelow joined Xconomy from the business desk of the San Diego Union-Tribune. He was a member of the team of reporters who were awarded the 2006 Pulitzer Prize in National Reporting for uncovering bribes paid to San Diego Republican Rep. Randy “Duke” Cunningham in exchange for special legislation earmarks. He also shared a 2006 award for enterprise reporting from the Society of Business Editors and Writers for “In Harm’s Way,” an article about the extraordinary casualty rate among employees working in Iraq for San Diego’s Titan Corp. He has written extensively about the 2002 corporate accounting scandal at software goliath Peregrine Systems. He also was a Gerald Loeb Award finalist and National Headline Award winner for “The Toymaker,” a 14-part chronicle of a San Diego start-up company. He takes special satisfaction, though, that the series was included in the library for nonfiction narrative journalism at the Nieman Foundation for Journalism at Harvard University. Bigelow graduated from U.C. Berkeley in 1977 with a degree in English Literature and from the Columbia University Graduate School of Journalism in 1979. Before joining the Union-Tribune in 1990, he worked for the Associated Press in Los Angeles and The Kansas City Times.